| Literature DB >> 17171718 |
Andreas Reik1, Yuanyue Zhou, Trevor N Collingwood, Lyndon Warfe, Victor Bartsevich, Yanhong Kong, Karla A Henning, Barrett K Fallentine, Lei Zhang, Xiaohong Zhong, Yann Jouvenot, Andrew C Jamieson, Edward J Rebar, Casey C Case, Alan Korman, Xiao-Yong Li, Amelia Black, David J King, Philip D Gregory.
Abstract
Increasing the yield of therapeutic proteins from mammalian production cell lines reduces costs and decreases the time to market. To this end, we engineered a zinc finger protein transcription factor (ZFP TF) that binds a DNA sequence within the promoter driving transgene expression. This ZFP TF enabled >100% increase in protein yield from CHO cells in transient, stable, and fermentor production run settings. Expression vectors engineered to carry up to 10 ZFP binding sites further enhanced ZFP-mediated increases in protein production up to approximately 500%. The multimerized ZFP binding sites function independently of the promoter, and therefore across vector platforms. CHO cell lines stably expressing ZFP TFs demonstrated growth characteristics similar to parental cell lines. ZFP TF expression and gains in protein production were stable over >30 generations in the absence of antibiotic selection. Our results demonstrate that ZFP TFs can rapidly and stably increase protein production in mammalian cells. (c) 2006 Wiley Periodicals, Inc.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17171718 DOI: 10.1002/bit.21304
Source DB: PubMed Journal: Biotechnol Bioeng ISSN: 0006-3592 Impact factor: 4.530